Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.
Jul 13, 2026, 5:59 PM ETBitcoin USD (BTC-USD) Crypto, BTC, ETH-USD Crypto, ETH, SOL-USD Crypto, XRP-USD Crypto, XRP, ZEC-USD CryptoBy:...
Tech shares pulled U.S. stocks lower on Monday after President Donald Trump announced that he would reinstate a blockade on...
The 41-page lawsuit Apple filed against OpenAI for allegedly stealing trade secrets is a good read. Unless you’re OpenAI, that...
The German government made it clear today that any vote on a boycott or toughening of trade terms with...
An sNDA filed by BioMarin Pharmaceutical (BMRN) seeking full approval of its achondroplasia treatment Voxzogo (vosoritide) has been accepted by...
SK Hynix's US-listed shares fell nearly 8% in early trade on Monday, giving up part of Friday’s strong debut gains...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
